Derek Archila
Stock Analyst at Wells Fargo
(4.51)
# 482
Out of 5,182 analysts
235
Total ratings
56.88%
Success rate
19.49%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Downgrades: Equal-Weight | $26 → $41 | $40.95 | +0.12% | 15 | Apr 17, 2026 | |
| SLNO Soleno Therapeutics | Downgrades: Equal-Weight | $110 → $53 | $52.75 | +0.47% | 5 | Apr 17, 2026 | |
| NRIX Nurix Therapeutics | Maintains: Overweight | $29 → $28 | $16.49 | +69.80% | 9 | Apr 9, 2026 | |
| VRDN Viridian Therapeutics | Maintains: Equal-Weight | $29 → $20 | $13.50 | +48.15% | 4 | Mar 31, 2026 | |
| ALXO ALX Oncology Holdings | Initiates: Overweight | $5 | $1.59 | +214.47% | 1 | Mar 19, 2026 | |
| GLUE Monte Rosa Therapeutics | Maintains: Overweight | $30 → $29 | $19.29 | +50.34% | 10 | Mar 18, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Overweight | $136 → $143 | $85.20 | +67.84% | 9 | Mar 12, 2026 | |
| SEPN Septerna | Maintains: Overweight | $28 → $48 | $25.07 | +91.50% | 6 | Mar 3, 2026 | |
| IRON Disc Medicine | Maintains: Overweight | $78 → $79 | $68.85 | +14.74% | 3 | Mar 2, 2026 | |
| ARGX argenx SE | Maintains: Overweight | $1,317 → $1,247 | $783.74 | +59.11% | 16 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $88 → $98 | $74.52 | +31.51% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $107 → $101 | $95.72 | +5.52% | 13 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $322 → $330 | $226.66 | +45.59% | 16 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $479 → $376 | $308.51 | +21.88% | 2 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $39 | $24.75 | +57.58% | 2 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $33 | $8.99 | +267.07% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $69 → $116 | $86.68 | +33.83% | 10 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $25 | $10.19 | +145.34% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $27 | $6.10 | +342.62% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $10.29 | +45.77% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $81 | $66.59 | +21.64% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $30 | $44.65 | -32.81% | 4 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $7.29 | -31.41% | 12 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $10 | $2.83 | +253.36% | 6 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $1 | $0.79 | +26.44% | 3 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $44 → $38 | $33.66 | +12.89% | 4 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $40 → $30 | $33.59 | -10.69% | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $2 | $2.91 | -31.27% | 11 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $4.25 | +17.65% | 5 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $15 | $5.47 | +174.22% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $14 | $28.56 | -50.98% | 5 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $45 | $28.62 | +57.23% | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $37 → $20 | $1.91 | +947.12% | 7 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.13 | +250.88% | 1 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $298 → $193 | $28.55 | +576.01% | 1 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $61 → $41 | $87.75 | -53.28% | 1 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $480 → $160 | $13.93 | +1,048.60% | 3 | Mar 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $180 → $60 | $20.39 | +194.26% | 3 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $29 | $6.79 | +327.10% | 4 | Dec 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $50 | $1.19 | +4,101.68% | 2 | Jun 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $51 | $23.77 | +114.56% | 1 | Nov 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $88 | $11.49 | +665.88% | 1 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $25.55 | - | 1 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $31.26 | - | 2 | Aug 3, 2017 |
Apellis Pharmaceuticals
Apr 17, 2026
Downgrades: Equal-Weight
Price Target: $26 → $41
Current: $40.95
Upside: +0.12%
Soleno Therapeutics
Apr 17, 2026
Downgrades: Equal-Weight
Price Target: $110 → $53
Current: $52.75
Upside: +0.47%
Nurix Therapeutics
Apr 9, 2026
Maintains: Overweight
Price Target: $29 → $28
Current: $16.49
Upside: +69.80%
Viridian Therapeutics
Mar 31, 2026
Maintains: Equal-Weight
Price Target: $29 → $20
Current: $13.50
Upside: +48.15%
ALX Oncology Holdings
Mar 19, 2026
Initiates: Overweight
Price Target: $5
Current: $1.59
Upside: +214.47%
Monte Rosa Therapeutics
Mar 18, 2026
Maintains: Overweight
Price Target: $30 → $29
Current: $19.29
Upside: +50.34%
Rhythm Pharmaceuticals
Mar 12, 2026
Maintains: Overweight
Price Target: $136 → $143
Current: $85.20
Upside: +67.84%
Septerna
Mar 3, 2026
Maintains: Overweight
Price Target: $28 → $48
Current: $25.07
Upside: +91.50%
Disc Medicine
Mar 2, 2026
Maintains: Overweight
Price Target: $78 → $79
Current: $68.85
Upside: +14.74%
argenx SE
Feb 27, 2026
Maintains: Overweight
Price Target: $1,317 → $1,247
Current: $783.74
Upside: +59.11%
Feb 13, 2026
Maintains: Overweight
Price Target: $88 → $98
Current: $74.52
Upside: +31.51%
Feb 11, 2026
Maintains: Equal-Weight
Price Target: $107 → $101
Current: $95.72
Upside: +5.52%
Jan 20, 2026
Maintains: Overweight
Price Target: $322 → $330
Current: $226.66
Upside: +45.59%
Jan 20, 2026
Maintains: Equal-Weight
Price Target: $479 → $376
Current: $308.51
Upside: +21.88%
Jan 6, 2026
Maintains: Overweight
Price Target: $17 → $39
Current: $24.75
Upside: +57.58%
Dec 16, 2025
Maintains: Overweight
Price Target: $31 → $33
Current: $8.99
Upside: +267.07%
Dec 9, 2025
Maintains: Overweight
Price Target: $69 → $116
Current: $86.68
Upside: +33.83%
Dec 8, 2025
Maintains: Overweight
Price Target: $19 → $25
Current: $10.19
Upside: +145.34%
Nov 19, 2025
Maintains: Overweight
Price Target: $14 → $27
Current: $6.10
Upside: +342.62%
Nov 6, 2025
Maintains: Overweight
Price Target: $16 → $15
Current: $10.29
Upside: +45.77%
Nov 5, 2025
Maintains: Overweight
Price Target: $51 → $81
Current: $66.59
Upside: +21.64%
Oct 21, 2025
Maintains: Equal-Weight
Price Target: $36 → $30
Current: $44.65
Upside: -32.81%
Oct 17, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $7.29
Upside: -31.41%
Sep 23, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $2.83
Upside: +253.36%
Sep 16, 2025
Downgrades: Equal-Weight
Price Target: $25 → $1
Current: $0.79
Upside: +26.44%
Aug 20, 2025
Maintains: Overweight
Price Target: $44 → $38
Current: $33.66
Upside: +12.89%
Aug 12, 2025
Maintains: Equal-Weight
Price Target: $40 → $30
Current: $33.59
Upside: -10.69%
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $2.91
Upside: -31.27%
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.25
Upside: +17.65%
Mar 12, 2025
Maintains: Equal-Weight
Price Target: $16 → $15
Current: $5.47
Upside: +174.22%
Dec 19, 2024
Maintains: Equal-Weight
Price Target: $12 → $14
Current: $28.56
Upside: -50.98%
Dec 19, 2024
Maintains: Overweight
Price Target: $47 → $45
Current: $28.62
Upside: +57.23%
May 5, 2021
Downgrades: Hold
Price Target: $37 → $20
Current: $1.91
Upside: +947.12%
Aug 4, 2020
Initiates: Buy
Price Target: $18
Current: $5.13
Upside: +250.88%
Jul 10, 2020
Downgrades: Hold
Price Target: $298 → $193
Current: $28.55
Upside: +576.01%
Apr 15, 2020
Reiterates: Buy
Price Target: $61 → $41
Current: $87.75
Upside: -53.28%
Mar 31, 2020
Maintains: Hold
Price Target: $480 → $160
Current: $13.93
Upside: +1,048.60%
Mar 17, 2020
Downgrades: Hold
Price Target: $180 → $60
Current: $20.39
Upside: +194.26%
Dec 11, 2018
Downgrades: Perform
Price Target: $29
Current: $6.79
Upside: +327.10%
Jun 22, 2018
Maintains: Outperform
Price Target: $34 → $50
Current: $1.19
Upside: +4,101.68%
Nov 15, 2017
Maintains: Outperform
Price Target: $32 → $51
Current: $23.77
Upside: +114.56%
Sep 7, 2017
Initiates: Outperform
Price Target: $88
Current: $11.49
Upside: +665.88%
Sep 7, 2017
Initiates: Market Perform
Price Target: n/a
Current: $25.55
Upside: -
Aug 3, 2017
Downgrades: Perform
Price Target: n/a
Current: $31.26
Upside: -